Читать книгу Uric Acid in Chronic Kidney Disease - Группа авторов - Страница 29

1 Beck LH: Requiem for gouty nephropathy. Kidney Int 1986;30:280–287.

2 Waisman J, Mwasi LM, Bluestone R, Klinenberg JR: Acute hyperuricemic nephropathy in rats. An electron microscopic study. Am J Pathol 1975;81:367–378.

3 Hoffstein S, Weissmann G: Mechanisms of lysosomal enzyme release from leukocytes. IV. Interaction of monosodium urate crystals with dogfish and human leukocytes. Arthritis Rheum 1973;18:153–165.

4 Fogo AB, Kashgarian M: Tubulointerstitial Diseases, Urate Nephropathy, in Diagnostic Atlas of Renal Pathology, ed 3. Philadelphia, Elseiver, 2017, p 446.

5 Johnson R, Nakagawa T, Jalal D, Sanchez-Lozada LG, Kang DH, Ritz E: Uric acid and chronic kidney disease: which is chasing which? Nephrol Dial Transplant 2013;28:2221–2228.

6 González-Sanchez AG, Rubio-Jurado B, et al: Síndrome de lisis tumoral. El Residente 2013;8:35–43.

7 Scott CH, Jones DP, Ching-Hon P: The tumor lisys syndrome. N Engl J Med 2011:364:1844–1854.

8 Ejaz AA, Mu W, Kang DH, Roncal C, Sautin YY, Henderson G, Tabah-Fisch I, Keller B, Beaver TM, Nakagawa T, Johnson RJ: Could uric acid have a role in acute renal failure? Clin J Am Soc Nephrol 2007;2:16–21.

9 Steele TH, Oppenheimer S: Factors affecting urate excretion following diuretic administration in man. Am J Med 1969;47:564–574.

10 Moe OW: Posing the question again: does chronic uric acid nephropathy exist? J Am Soc Nephrol 2010;21:395–397.

11 Sánchez-Lozada LG, Lanaspa MA, Cristóbal-García M, García-Arroyo F, Soto V, Cruz-Robles D, Nakagawa T, Yu MA, Kang DH, Johnson RJ: Uric acid-induced endothelial dysfunction is associated with mitochondrial alterations and decreased intracellular ATP concentrations. Nephron Exp Nephrol 2012;121:e71–e77.

12 Treviño-Becerra A: Hypertriglyceridaemia and hyperuricaemia in IgA nephropathy. Nephrol Dial Transplant 2011;16:639.

13 Ficociello LH, Rosolowsky ET, Niewczas MA, Maselli NJ, Weinberg JM, Aschengrau A, Eckfeldt JH, Stanton RC, Galecki AT, Doria A, Warram JH, Krolewski AS: High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up. Diabetes Care 2010;33:1337–1343.

14 Johnson RJ, Kivlighn SD, Kim YG, et al: Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease. Am J Kidney Dis 1999;33:225–234.

15 Jossa F, Farinaro E, Panico S, Krogh V, Celentano E, Galasso R, Mancini M, Trevisan M: Serum uric acid and hypertension: the Olivetti heart study. J Hum Hypertens 1994;8:677–681.

16 Kahn HA, Medalie JH, Neufeld HN, Riss E, Goldbourt U: The incidence of hypertension and associated factors: the Israel ischemic heart disease study. Am Heart J 1972;84:171–182.

17 Grahame R, Scott JT: Clinical survey of 354 patients with gout. Ann Rheum Dis 1970;29:461–468.

18 Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K: Serum uric acid and risk for development of hypertension and impaired fasting glucose or type II diabetes in Japanese male office workers. Eur J Epidemiol 2003;18:523–530.

19 Hunt SC, Stephenson SH, Hopkins PN, Williams RR: Predictors of an increased risk of future hypertension in Utah. A screening analysis. Hypertension 1991;17(6 pt 2):969–976.

20 Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, Wamsley A, Sheikh-Hamad D, Lan HY, Feng L, Johnson RJ: Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003;41:1287–1293.

21 Feig DI: The role of uric acid in the pathogenesis of hypertension in the young. J Clin Hypertension 2012;14:346–352.

22 Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, Kang DH, Gordon KL, Watanabe S, Nakagawa T, Lan HY, Johnson RJ: Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 2002;282:F991–F997.

23 Nakagawa T, Mazzali M, Kang DH, Sánchez-Lozada LG, Herrera-Acosta J, Johnson RJ: Uric acid – a uremic toxin? Blood Purif 2006;24:67–70.

24 Soltani Z, Rasheed K, Kapusta DR, Reisin E: Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? Curr Hypertens Rep 2013;15:175–181.

25 Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, Patel JM, Johnson RJ: A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 200;290:F625–F631.

26 Khosla UM, et al: Hyperuricemia induces endothelial dysfunction. Kidney Int 2005;67:1739–1742.

27 Akgul A: Is uric acid a predictive factor for graft dysfunction in renal transplant recipients? Transplant Proc 2007;39:1023–1026.

28 Haririan A, et al: Association of serum uric acid with graft survival after kidney transplantation: a time-varying analysis. Am J Transplant 2011;11:1943–1950.

29 Bellomo G: Asymptomatic hyperuricemia following renal transplantation. World J Nephrol 2015;4:324–329.

30 Hart A, Jackson S, Kasiske BL, Mauer MS, Najafian B, Matas AJ, Spong R, Ibrahim HN: Uric acid and allograft loss from interstitial fibrosis/tubular atrophy: post hoc analysis from the angiotensin II blockade in chronic allograft nephropathy trial. Transplantation 2014;97:1066–1071.

Carlos Enrique Méndez Landa

Department of Nephrology, General Hospital and Medical Unit Ambulatory Care

Elpidio Cortes Street, San Pedro Xalpa Colony, Azcapotzalco

02719, Mexico City (Mexico)

E-Mail ashkeloningvar@gmail.com